Susan Greenfield speaking at OBN’s BioTuesday

Susan Greenfield speaking at OBN’s BioTuesday

Susan would like to mention her following thoughts with regards to the OBN presentation: “Our technology is based on the previously unknown neurochemical (T14), that is doubled in the Alzheimer brain. We are developing a pre-symptomatic screen where T14 could be...